Disclosure: This site may earn affiliate commissions when you click provider links. This doesn't affect our recommendations. Learn more

GLP-1 Without Insurance: Your Real Options in 2026

Brand-name GLP-1s cost $1,000+/month without coverage. Here's what actually works: compounded semaglutide, manufacturer programs, and cash-pay options compared.

RxPickr Editorial TeamUpdated October 7, 2026

Brand-name GLP-1 medications like Wegovy and Zepbound carry retail pharmacy prices of $1,000 to $1,650 per month without insurance (GoodRx retail pricing). For most people, that's not realistic. If you do have insurance, our GLP-1 insurance coverage guide covers prior authorization and how to maximize your benefits. A few things are worth knowing upfront: Novo Nordisk offers Wegovy through a direct self-pay program at $199/month for the first 2 fills at starter doses (an intro window recently extended through December 31, 2026), stepping up to $349/month afterward, with the Wegovy pill starting at $149/month, though that price covers only the 1.5mg dose (4mg is $199/month, 9mg and 25mg are $299/month). Check wegovy.com for current pricing as it is actively changing. Eli Lilly sells Zepbound directly through LillyDirect (lilly.com/lillydirect) at $299–$449/month for self-pay patients. And compounded semaglutide from licensed telehealth providers starts at $99/month. This guide covers all three paths so you can choose what fits your situation.

Last verified: October 2026 by RxPickr Editorial Team (a few figures were carried from an earlier cycle because the provider's site blocked our checks: Hers, Oak Longevity, bmiMD, TrimRx, and MEDVi's compounded prices are carried from September 1, and PlushCare's Zepbound and Wegovy figures from May; see the pricing tool for per-entry dates). Every monthly price below was confirmed against the provider's public pricing page or a completed intake quote in our monthly pricing refresh. We re-verify pricing monthly. Our full methodology is at How we rate providers.

On Medicare? As of July 1, 2026, you may not need cash-pay at all. The Medicare GLP-1 Bridge, a temporary CMS program running through December 2027, covers Wegovy, Foundayo, and Zepbound (KwikPen) for chronic weight management at a flat $50 monthly copay for eligible beneficiaries. Our Medicare GLP-1 Bridge guide covers eligibility and the process. The options below remain relevant if you don't qualify.

Find the best GLP-1 provider for your budget

Answer 10 questions and we'll match you with the most cost-accessible option for your situation.

Take the free quiz →

Option 1: Compounded semaglutide

Compounded semaglutide is produced by licensed compounding pharmacies using the same active ingredient as brand-name Wegovy and Ozempic. It is not FDA-approved as a finished product — an important distinction. Oversight varies by pharmacy type: 503B outsourcing facilities are FDA-registered and subject to federal quality standards (FDA compounding overview), while the 503A compounding pharmacies that now supply most compounded semaglutide operate under state pharmacy board oversight.

For patients paying out of pocket, cost is the defining advantage. Typical all-inclusive compounded semaglutide pricing from reputable telehealth providers runs $99 to $299 per month verified in October 2026, depending on plan and provider, well below the retail pharmacy price for brand-name options.

Why is it cheaper? Compounding pharmacies don't go through FDA's full drug approval process, which carries enormous R&D and manufacturing costs. They also don't carry brand premiums. You're paying for the active ingredient and the compounding process, not a patented finished product.

What to look for in a provider:

  • Ask whether they use a licensed 503A or 503B compounding pharmacy and confirm their current legal status. The FDA issued a clarification in April 2026 restricting 503B facilities from using bulk semaglutide API, so many providers now use 503A pharmacies. A transparent provider will confirm which type they use and that they have no outstanding FDA notices.
  • Ask whether they provide a certificate of analysis (CoA) for each batch.
  • Avoid providers that add unauthorized additives such as B12 or cyanocobalamin without clinical justification. The FDA has flagged this practice as a safety concern (FDA April 2026 clarification).
  • Confirm that the total price includes medication, supplies, and follow-up visits. Some providers charge these separately.

Option 2: Manufacturer savings programs

Novo Nordisk and Eli Lilly each offer savings programs for their GLP-1 medications. The programs are real, but the eligibility criteria mean most uninsured patients won't qualify.

Novo Nordisk Wegovy savings program: Novo Nordisk offers a savings card that may reduce Wegovy costs to as low as $25 per month for eligible commercially insured patients (Wegovy savings page). The catch: eligibility requires commercial insurance that covers Wegovy. Patients without insurance, or with Medicare or Medicaid coverage, are generally not eligible per the program terms. If you have employer-sponsored commercial insurance but a high copay, this is worth checking. Without any insurance, it is unlikely to apply.

Eli Lilly Zepbound savings card: Lilly's savings card program for Zepbound (tirzepatide) works similarly. Qualifying commercially insured patients may pay as little as $25 per fill (Zepbound savings page). Again, uninsured patients typically do not qualify. Lilly does offer Zepbound vials through its LillyDirect program at $299 to $449 per month for self-pay patients, which is a genuinely lower cash price than retail pharmacy — without requiring insurance.

The honest summary: if you have no insurance at all, manufacturer savings cards are designed for commercially insured patients and you will likely hit a wall. LillyDirect's self-pay vial pricing is the notable exception. And if the reason you're excluded from savings cards is Medicare coverage, check the Medicare GLP-1 Bridge first: its $50 monthly copay beats every cash-pay option on this page.

Option 3: GoodRx and cash-pay brand-name

GoodRx and similar pharmacy discount programs can reduce the cash price of Ozempic and Wegovy at participating pharmacies. With a GoodRx coupon, Ozempic (0.5mg, 2 pens) has been available for approximately $800 to $950 per month at some pharmacies, though prices vary by location and change frequently (GoodRx Ozempic pricing).

This is still expensive. But for patients who specifically want brand-name semaglutide, have no insurance, and can afford this range, it's a legitimate path. The steps are straightforward: search GoodRx for your medication and dose, find a participating pharmacy nearby, and present the coupon at pickup. GoodRx does not require a membership for basic coupons.

Wegovy's GoodRx price runs higher, typically $900 to $1,200 per month at cash pay, because the 2.4mg weight-loss indication carries a different pricing tier than Ozempic.

Providers that work well without insurance

These providers are consistently among the most cost-accessible options for uninsured patients based on pricing verified by RxPickr in October 2026.

Provider (domain)Monthly cost (verified October 2026)MedicationNotes
Eden (eden.health)$99/mo (sema) or $129/mo (tirz), all-inclusive at every dose, month to monthCompounded semaglutide or tirzepatideNo membership fee for compounded medication; brand-name products still require a $99/mo membership
Mochi Health (joinmochi.com)$139–$178/mo (sema) or $169–$278/mo (tirz), by dose, plus a $79/mo membership ($0 first month on the 1-month plan)Compounded semaglutide or tirzepatideSwitched to per-dose pricing in August 2026; dietitian access included
Shed (tryshed.com)From $149/mo (Microdose); full-dose sema cut to $159/mo (12-mo plan)Compounded semaglutideLow-cost no-commitment all-inclusive option; multiple formats including injection, sublingual, and lozenge
Found (joinfound.com)From $169/mo all-in (12-mo plan); $289/mo month-to-monthCompounded semaglutide, tirzepatide, or liraglutideMedication included in one plan price; free insurance check and full coaching
Henry Meds (henrymeds.com)$179/mo (sublingual) or $197–$297/mo (injection, depending on commitment)Compounded semaglutideAll-inclusive: medication, visits, supplies
TrimRx (trimrx.com)$199/mo (sema) or $349/mo (tirz), flat at every dose; 12-mo prepay from $174/$283Compounded semaglutide or tirzepatideAll-inclusive, licensed compounding pharmacy
Oak Longevity (oaklovesyou.com)$133/mo (sema) or $199/mo (tirz) on a 3-month supply with checkout code ($200/$250/mo month to month)Compounded semaglutide or tirzepatideNo membership; not available in West Virginia or Mississippi; checkout FAQ notes dose steps may add $50–$75
LillyDirect (lilly.com/lillydirect)$299–$449/moFDA-approved Zepbound (tirzepatide)Direct from manufacturer; vial self-injection required
NovoCare Pharmacy (novocare.com)$149–$299/mo by dose (Wegovy pill); $199/mo intro penFDA-approved Wegovy + OzempicDirect from Novo Nordisk; requires existing Rx; the $149 rate now covers only the 1.5mg starting dose

Eden is now the lowest verified price on this list: $99/month for compounded semaglutide and $129/month for compounded tirzepatide, all-inclusive with no membership fee and no commitment (Eden dropped its separate $99/month membership for compounded GLP-1s after our September check). Mochi Health is next at the starting dose, $139/month for compounded semaglutide, though its per-dose pricing climbs to $178/month by the top dose. Shed Microdose at $149/month is another no-commitment option, and Shed's full-dose compounded semaglutide was just cut to $159/month on the 12-month plan. Found's all-in plan at $169/month (12-month plan) includes the compounded medication in one price. Henry Meds' cheapest published rate is $179/month for sublingual semaglutide, and TrimRx holds a flat $199/month at every dose. Oak Longevity is confirmed at $133/month on a 3-month supply with its checkout code ($200/month month to month). The trade-off at most compounded providers is minimal coaching; Found and Mochi Health include coaching or dietitian access. LillyDirect and NovoCare Pharmacy are the only options on this list offering FDA-approved brand-name medication in this price range: both are fulfillment-only and require an existing prescription from any licensed provider.

Paying out of pocket for a GLP-1: what to expect

Pros

  • No prior authorization process, so treatment can start faster
  • No insurance denials or appeals required
  • Access to compounded options at a fraction of brand-name cost
  • Full control over provider and medication choice

Cons

  • Significant monthly cost even for compounded options ($99–$399/mo depending on medication and plan)
  • Compounded medications are not FDA-approved as finished products
  • No insurance safety net if you have a medical complication
  • Manufacturer savings programs typically exclude uninsured patients
  • Regulatory availability of compounded GLP-1s may change

Henry Meds

Compounded semaglutide from $179/mo (sublingual); injection $197–$297/mo by commitment (October 2026)

All-inclusive flat pricing with no separate membership fee stacked on top of medication.

Visit Henry Meds →

TrimRx

Compounded semaglutide $199/mo, flat at every dose; 12-mo prepay from $174/mo (September 2026)

Simple all-inclusive pricing from a licensed compounding pharmacy.

Visit TrimRx →

What to do next

Start by deciding whether compounded or brand-name is the right fit for you. If cost is the primary constraint and you've researched the regulatory context, compounded semaglutide from a licensed provider is the most practical path for most uninsured patients. If you specifically want brand-name tirzepatide, LillyDirect's self-pay pricing is worth a direct look.

Before starting any GLP-1 medication, consult your healthcare provider. A telehealth clinician at any of the providers above can conduct a clinical evaluation and issue a prescription if you're a candidate, but GLP-1 medications require a prescription and medical supervision.